Background {#Sec1}
==========

Tuberculosis (TB) is an ongoing public health issue with Canadian-born Indigenous peoples disproportionately affected. Between 1970 and 2010, the proportion of active TB cases in Canadian-born Indigenous peoples increased from 14.7 to 21.2% \[[@CR1]\]. Indigenous communities experience higher rates of active TB disease than Canadian non-Indigenous populations. Determinants of TB infection and disease differ between Canadian Indigenous peoples and Canadian non-Indigenous populations \[[@CR2]\]. Canadian Indigenous peoples experience significant differences in terms of comorbidities, transmission factors, and social determinants of health, compared to the non-Indigenous population \[[@CR2]\].

In the Canadian territory of Nunavut specifically, there were 581 TB cases reported to the Nunavut Department of Health in a 10-year period between 1999 and 2011 \[[@CR3]\]. Almost all reported cases between 1999 and 2011 (98.8%) were of Inuit origin \[[@CR3]\]. In 2010, the highest annual number of cases was reported in Nunavut with 100 active cases (304.7 cases per 100,000 population) identified \[[@CR4]\]. In 2012, the TB incidence rate in Nunavut (which is home to 49% of the total Inuit population in Canada) was 234 cases per 100,000 population, almost 50 times the overall Canadian rate (4.8 per 100,000) \[[@CR4]\]. In Nunavut, over 90% of identified active TB cases between 1999 and 2011 received treatment with adherence rates of 80% or better \[[@CR3]\]. Public health awareness campaigns have demonstrated success in increasing TB testing rates within Iqaluit, the capital of Nunavut. However, this level of testing was not sustained after the completion of the awareness campaigns \[[@CR5]\]. The First Nations and Inuit Health Branch (FNIHB) of the Government of Canada set a goal of reducing TB in the Inuit population of Canada to 3.6 cases per 100,000 population by 2015 \[[@CR2]\]. Recent data indicate that this goal has not been met, suggesting that additional public health strategies in addition to routine contact tracing and screening are necessary to address TB in Nunavut \[[@CR5]\].

The prevalence of socioeconomic factors that contribute to infection and disease is a particular challenge to controlling TB in Nunavut \[[@CR6], [@CR7]\]. Overcrowded housing with poor ventilation is common \[[@CR8]\], and may facilitate the transmission of TB and other airborne respiratory infections \[[@CR7]\]. There have been calls for additional resources for increased access to diagnostic testing, treatment, contact tracing, and more comprehensive screening programs, as well as more long-term investments to address housing, poverty, and food security \[[@CR7]\].

While TB shares many attributes with other communicable diseases, it is distinguished by the high frequency with which latent infection occurs, and by the tendency of a small percentage of latent infections to reactivate and progress to active TB disease years or decades after initial infection \[[@CR9]\]. This complicates the control of TB, as high TB rates in communities are likely be due to a combination of recent transmission events and reactivation of infection in latently infected individuals.

Given the unique characteristics of TB, including potentially long lags between infection and disease onset and the challenges of conducting sufficiently powered trials \[[@CR10]\], disease transmission models are frequently used to evaluate the impact of TB control policy options \[[@CR11]--[@CR15]\]. These models facilitate the evaluation of different strategies that might impact TB control, such that we can gain a better idea of how best to allocate limited resources in a way that minimizes disease transmission and protects the health of at-risk populations.

We sought to develop a stochastic, agent-based simulation model to describe TB transmission and evaluate different intervention strategies that might be used to control the spread of TB in Canada's north. The model focused on the Kivalliq Region of Nunavut, which encompasses seven communities and is an area that continues to experience a high burden of TB \[[@CR16]\].

Methods {#Sec2}
=======

Model overview {#Sec3}
--------------

We developed an agent-based simulation model of *Mycobacterium tuberculosis* transmission in the Kivalliq Region of Nunavut, Canada (Fig. [1](#Fig1){ref-type="fig"}). The region has a population of 8952 residents and is home to seven distinct communities ranging in size from 310 to 2320 individuals \[[@CR3]\]. This model represents individuals (agents) within a simulated environment, and their interactions, movements, decision-making, and related health states. We used an agent-based approach to account for the small population size and associated stochasticity. This approach allowed us to model the unique household and community structure in this region, and to record the health states and treatment histories of individuals over time. The model was constructed using the AnyLogic software package (<http://www.anylogic.com/>). Model parameters were region-specific, wherever possible, or derived from the biomedical literature (Table [1](#Tab1){ref-type="table"}).Fig. 1Map showing the location of the Territory of Nunavut as well as the three distinct geographic regions. Kivalliq is the southernmost region and borders Hudson Bay Table 1Model parameters, values, ranges, and sourcesParameterDetailsValueSource*Tuberculosis Natural History Parameters*Probability of transmission (per contact)0.1Abu-Raddad \[[@CR12]\]Number of respiratory contacts (per year)40--1000Estimated by model calibrationProportion of transmission occurring in communityVaried0.01--0.15AssumptionProportion of new infections entering latent fast state (active disease in \<5 years)Abu-Raddad \[[@CR12]\]Adult0.15Child0.05Progression to active disease (per year)Fast progressor1.5Abu-Raddad \[[@CR12]\]Progression to active disease (lifetime probability, rate dependent on age at infection)Slow progressor0.05Abu-Raddad \[[@CR12]\]Proportion of active cases with extrapulmonary diseaseKivalliq surveillance dataAdult0.11Child0.042Proportion of active cases with high transmissibility pulmonary diseaseKivalliq surveillance dataAdult0.3Child0.043Proportion of active cases with low transmissibility pulmonary diseaseKivalliq surveillance dataAdult0.59Child0.915Infectivity (relative to high transmissibility TB)Abu-Raddad \[[@CR12]\]Low transmissibility TB0.25Extrapulmonary TB0Spontaneous recovery rate (per year)0.1Abu-Raddad \[[@CR12]\]Relative susceptibility to re-infectionResusceptible individuals0.6Vynnycky \[[@CR33]\]Probability of TB-attributable mortality with active disease0.0094Kivalliq surveillance data*Population and Community Characteristics*Number of communities7Census \[[@CR18]\]Initial number of households1890Census \[[@CR19]\]Average household size4Census \[[@CR18]\]Number of new households added (per year)30Census \[[@CR18]\]Proportion of population \<15 years of age0.35Census \[[@CR18]\]Initial number of individuals diagnosed and on treatment2Kivalliq surveillance dataInitial number of individuals in different states (remaining are susceptible)Estimated by model calibrationUndiagnosed LTBI10--2000Undiagnosed active TB disease1--50Resusceptible (following treatment or spontaneous recovery)50--3000Birth rate (per year)Females aged 15--440.1Nunavut Bureau of Statistics \[[@CR21]\]Mortality rateAge-specific, estimated from Nunavut life tablesStatistics Canada \[[@CR20]\]*Screening and Treatment Parameters*Time to diagnosis for active TB diseaseTian \[[@CR27]\]High0.5Low0.64Extrapulmonary0.64Time in treatment (years)Active TB disease0.6Kivalliq surveillance dataProbability lost to follow-up while on treatment for active TB diseaseKivalliq surveillance dataAdult0.06Child0.04Passive population screening for LTBI (per year)0.004TAIMA TB report \[[@CR34]\]Average time to LTBI treatment initiation for cases identified by population screening (months)1AssumptionAverage time to completion of contact tracing (months)2Tian \[[@CR13]\]Time on treatment for LTBI (years)0.75Canadian TB Standards \[[@CR24]\]Probability LTBI treatment is completed0.7Alvarez \[[@CR5]\]

A brief summary of the model structure and calibration procedure is provided below, with a more complete description included in the Additional file [1](#MOESM1){ref-type="media"}.

Population and community structure {#Sec4}
----------------------------------

To reflect the demographic structure of Kivalliq, individuals in the model were assigned an age, sex, household, and community. The initial age distribution of the population was based on 2001 Canadian census estimates for the Kivalliq Region \[[@CR17]\]. Each individual was assigned to a household, which in turn was located within one of the seven communities. Average household size was based on census data \[[@CR18], [@CR19]\]. New households were added every year. Individuals were added to the model population by birth and left the population by death, with rates based on Nunavut data (Table [1](#Tab1){ref-type="table"}) \[[@CR20], [@CR21]\]. Although we allowed for movement between communities (described in Additional file [1](#MOESM1){ref-type="media"}), we did not model migration into or out of the region.

Natural history of tuberculosis {#Sec5}
-------------------------------

After the initial synthetic model population was created as described above (agents assigned specific, individual attributes including an age, sex, household size, community, and specific individual household members), agents within the synthetic population were assigned a health state based on the TB natural history component of the model (Fig. [2](#Fig2){ref-type="fig"}). This aspect of the model represented each individual's health state over time. We included the following stages of the natural history of TB: susceptible, latent TB infection (LTBI), active disease, and resusceptible. Susceptible individuals are TB naïve, having never been infected by TB before and can become infected if they come in contact with an individual with an active TB infection. Individuals who have been recently infected progress to the the latent TB classes (latent fast or latent slow). In this case, a small proportion of individuals will go on to develop active pulmonary TB within a period of 5 years (Table [1](#Tab1){ref-type="table"}) with the remainder staying in the latent slow class where they can stay indefinitely or they can progress to the active TB state at some time in the future \[[@CR22]\]. The active TB states are broken down into three distinct compartments: high-transmissibility, low transmissibility, and extrapulmonary active TB. Individuals in the high-transmissibility compartment are individuals who have smear-positive, pulmonary TB. These individuals are considered more infectious than individuals diagnosed with pulmonary TB but who are smear-negative (Table [1](#Tab1){ref-type="table"}) \[[@CR22]\]. We assume that individuals who are diagnosed with extrapulmonary TB are not infectious to others \[[@CR22]\]. Individuals in either the LTBI states or the active TB states can transition into the 'diagnosed and treated' compartment based on parameters describing the rate of diagnosis and treatment of TB cases in Kivalliq, Nunavut (Table [1](#Tab1){ref-type="table"}). Individuals in the model who have been successfully treated for TB or who spontaneously clear their TB without receiving treatment (Table [1](#Tab1){ref-type="table"}), transition to the resusceptible compartment \[[@CR12], [@CR22]\]. Individuals in the resusceptible compartment can become reinfected but their risk of acquiring a new TB infection is reduced compared to a TB naïve individual (Table [1](#Tab1){ref-type="table"}) \[[@CR12]\]. Parameters describing all model transitions between states are presented in Table [1](#Tab1){ref-type="table"} and are informed by both the existing biomedical literature and data extracted from the Nunavut TB registry. To capture age-related differences in TB infection, progression, and management, we classified individuals aged \<15 years as 'children', and those aged ≥15 as 'adults' based on the age cut-offs used in the Canadian Tuberculosis Standards (7^th^ edition) and the age groupings available from the Nunavut Department of Health \[[@CR1], [@CR22], [@CR23]\]. We assumed that the majority of TB transmission occurred between individuals within a household (representing close contacts) \[[@CR22]\]. However, we also included a community network (encompassing all agents living within an individual's community) to allow us to investigate the contribution of community and casual contacts to TB transmission.Fig. 2Model overview. Only individuals with high or low transmissibility disease are infectious. All health states also have age-specific mortality, and the births are added to the susceptible state (not shown). The transition probabilities for certain health states differ depending on whether an individual is a child (\<15 years of age) or adults, as described in the text and Table [1](#Tab1){ref-type="table"}

Contact tracing and latent tuberculosis infection screening {#Sec6}
-----------------------------------------------------------

We assumed that susceptible individuals, as well as individuals with LTBI or undiagnosed active disease who had no prior history of treatment for LTBI or active disease, could undergo screening. Those diagnosed with LTBI and aged between 6 months and 65 years could receive treatment, with a proportion of these individuals completing treatment \[[@CR5], [@CR24]\]. Those diagnosed with active disease received appropriate treatment. All parameters describing baseline contact tracing and screening assumptions are found in Table [1](#Tab1){ref-type="table"}.

We assumed that contact tracing was only done for household contacts of diagnosed index cases. Identified household contacts with LTBI (meeting age and treatment history criteria) were offered treatment, with a proportion completing treatment based on Nunavut treatment completion data (Table [1](#Tab1){ref-type="table"}).

Model calibration {#Sec7}
-----------------

We used model calibration to estimate the number of individuals with latent, undiagnosed, or previously treated TB upon model initiation, as well as the annual number of respiratory contacts sufficient to transmit infection. To account for the fact that the risk of transmission is concentrated among close contacts (household contacts in our model), we assumed that the majority of respiratory contacts occurring between cases and their contacts occurred in the household. In our base case, we assumed that 5% of respiratory contacts sufficient for transmitting TB occurred within the community (with the remaining 95% of transmission-sufficient contacts occurring with household members). We also repeated the calibration process assuming that 1% or 15% of respiratory contacts occurred within the community. A total of 10 best-fit parameter sets were obtained for each value of community transmission.

Interventions to reduce tuberculosis burden {#Sec8}
-------------------------------------------

We considered different interventions to reduce the burden of TB in Kivalliq (Table [2](#Tab2){ref-type="table"}). For each intervention, changes made for that specific intervention were layered on top of the existing TB control activities that were assumed in our base case. For instance, there was a base case level of population LTBI screening in all interventions, which was increased in our population screening intervention. We included interventions that reduced TB transmission by active cases (interventions a and b), as well as those that prevented progression to active disease in LTBI cases (interventions c, d, and e):Table 2Model interventionsInterventionDetailsBase case• Time from active disease onset to treatment: 0.5 years for pulmonary high, 0.64 years for pulmonary low and extrapulmonary\
• Contact tracing time: 60 days\
• Population screening: 0.004/year\
• New households: 30/yearRapid treatment of active cases• Time from active disease onset to treatment initiation reduced by half (0.25 years for pulmonary high, 0.32 years for all other)Rapid contact tracing (CT)• Time to testing and treatment initiation for household contacts of diagnosed index cases reduced by half (30 days)Expanded population screening• Rate of general population screening (with appropriate treatment) increased to 0.01/yearsSchool screening• Screen all children aged 5, 11, and 14 annuallyIncreased housing to reduce overcrowding• Increase number of new households by 60/year *Rapid treatment of active cases:* This approach relies on the timely diagnosis of individuals with active TB, with rapid initiation of treatment, such that individuals are no longer infectious to others.*Increased housing to reduce overcrowding:* Another way of reducing TB transmission is by decreasing the effective number of case contacts. Since the majority of TB transmission is expected to occur in households, we evaluated increasing housing availability, thereby reducing the average household size and the number of individuals potentially exposed to an infectious individual in the household setting.*Rapid contact tracing*: Contact-tracing focuses on contacts of recently identified active cases, as these individuals are considered at high risk of infection. As screening and treatment of household contacts is already carried out as part of TB control activities, we evaluated the impact of reducing the time to carry out such investigations.*Population screening:* We evaluated the impact of increasing the rate of general population screening. Individuals were randomly selected from the pool of individuals in the population with no prior history of treated active or latent TB infection.*School screening:* Targeted screening of school-aged children has been recommended \[[@CR24]\]. We evaluated the impact of annual screening of children aged 5, 11, and 14 which is currently recommended in Nunavut \[[@CR7]\].

Model outcomes {#Sec9}
--------------

Intervention impact was evaluated by comparing the number of incident infections, LTBI diagnoses, and diagnosed active TB cases in the presence of the intervention to the base case. To account for variability in TB dynamics between model runs, comparisons of intervention impact were made *within* experiments; that is, for a given experiment with a best-fit parameter set estimated from the model calibration process, we compared outcomes in the presence of the different interventions to the base case. Results are presented as the median and interquartile range for the 10 experiments. We evaluated a 10-year time horizon, as this was considered relevant for public health decision-making. As an additional analysis, we considered a 25-year time horizon, given the slow progression of TB and the possible subsequent delay in observing changes in disease dynamics.

Supplementary analyses {#Sec10}
----------------------

We considered alternate approaches to evaluating intervention impact and to performing model calibration. A description of these approaches and results of these analyses are presented in the Additional file [1](#MOESM1){ref-type="media"}.

Results {#Sec11}
=======

Model calibration {#Sec12}
-----------------

The best-fit model realizations captured the variability in diagnosed pulmonary TB cases in Kivalliq over the 14-year time period (Fig. [3](#Fig3){ref-type="fig"}). Although our base case assumed 5% of contacts occurred within the community, we present the results of calibration for all three levels of community transmission for the sake of comparison. The proportion of incident cases in community contacts ranged from less than 1% to greater than 50%, depending on the assumed intensity of respiratory contacts occurring within the community (Fig. [4](#Fig4){ref-type="fig"}). For the 5% community contacts scenario, we estimated that the contact tracing process would identify a median of 22% of household contacts with LTBI and 1.3% of contacts with active TB infection. We observed similar estimates with lower or higher amounts of community transmission (Fig. [5](#Fig5){ref-type="fig"}).Fig. 3Model calibration. Model-projected (**a**) cumulative and (**b**) annual cases of pulmonary TB (median: solid line; minimum/maximum: dashed lines) compared to surveillance data for the Kivalliq region of Nunavut. Results represent the 10 best-fit model realizations, assuming that 5% of respiratory contacts sufficient for transmitting TB occur within the community. Results are similar for 1% and 15% of respiratory contacts in the community Fig. 4Proportion of incident infections projected to occur within the community over the 14-year calibration period. Model outputs assume different levels of TB transmission within the community. The remainder of infections occur among household contacts of active TB cases. Boxes represent the median values of 10 runs, while lines span the minimum and maximum values of 10 experiments with best-fit parameters Fig. 5Infection status of household members of active cases, identified by contact tracing. Household contacts of diagnosed cases of active TB disease had a probability of being identified and screened via the contact follow-up process, as described in the [Methods](#Sec2){ref-type="sec"}. Household members may be identified as having a latent TB infection (*blue boxes*), or active TB disease (*red boxes*). Remaining screened contacts are uninfected. Results are shown for different levels of TB transmission within the community. The midpoint, lower, and upper bounds of the boxes represent the median, 25^th^ percentile, and 75^th^ percentile, respectively. Bars span 1.5 times the interquartile range

Base case scenario {#Sec13}
------------------

For each of the best-fit model realizations, we used the model to examine the projected dynamics of TB in Kivalliq over a 10-year period, in the absence of any additional interventions (Fig. [6](#Fig6){ref-type="fig"}). The ten best-fit parameter sets resulted in a high degree of variability between model runs (due to stochasticity and a small population size), with cumulative TB incidence estimates ranging from 33--369 cases over the ten year time period. Compared to the base case, decreasing the time to treatment initiation for active cases was projected to reduce the number of incident TB infections in the population and have an impact on reducing diagnosed active TB (Fig. [7](#Fig7){ref-type="fig"}). This finding was consistent across the ten best-fit parameter set experiments. In addition, expanded population screening was projected to reduce the number of incident TB infections in the population and have an impact on reducing diagnosed active TB (Fig. [7](#Fig7){ref-type="fig"}). Increased housing at the level implemented in the model trended toward reducing TB incidence, but there was variability between model runs.Fig. 6Model-projected cumulative TB incidence and diagnosed cases of active TB over a 10-year period. Results are shown for the base case (i.e., no additional interventions), assuming 5% of respiratory contacts occur within the community. Each model run represents a best-fit parameter set obtained in the calibration process, as described in the [Methods](#Sec2){ref-type="sec"} and Additional file [1](#MOESM1){ref-type="media"} Fig. 7Projected impact of different interventions on incident TB infections and diagnoses of active TB disease. The midpoint of boxes represents the median percent change in the outcome of interest, relative to the base case, with the upper and lower bounds representing the 25^th^ and 75^th^ percentiles of percent change, respectively and the bars indicating 1.5 times the interquartile range. Results are based on cumulative outcomes over a 10-year time horizon, assuming 5% of transmission-sufficient respiratory contacts occur in the community. Intervention details are provided in Table [2](#Tab2){ref-type="table"}

As expected, compared to the base case, the two interventions that expanded LTBI screening (either at the population level or targeted to school aged children) resulted in more LTBI cases being detected (Fig. [8](#Fig8){ref-type="fig"}). However, greater LTBI detection and treatment did not necessarily translate into reduced TB burden: for the school-screening program, we did not observe a corresponding impact on incident or active TB diagnoses in the population. Reducing the time to identify, test, and where appropriate, treat contacts of infectious cases was not projected to have an impact on TB incidence or diagnoses.Fig. 8Projected impact of different interventions on diagnosed latent TB infections. Results represent cumulative excess cases, relative to the base case scenario, over a 10-year period, assuming that 5% of respiratory contacts sufficient to transmit TB occur with casual community contacts, with the remaining contacts occurring with household members. The midpoint, lower, and upper bounds of the boxes represent the median, 25^th^ percentile, and 75^th^ percentile of changes in cases, respectively. Bars span 1.5 times the interquartile range. Intervention details are provided in Table [2](#Tab2){ref-type="table"}

Sensitivity of results to model assumptions about transmission outside of households and time horizon {#Sec14}
-----------------------------------------------------------------------------------------------------

Our findings were sensitive to assumptions around the relative fraction of TB transmission occurring in communities versus households (Fig. [9](#Fig9){ref-type="fig"}). When the contribution of community transmission was relatively low (1% of contacts sufficient to transmit TB occurred outside of the household), expected TB incidence was low (17--66 cases in the base case over a 10-year period). None of the proposed interventions were expected to have a dramatic impact on TB burden in Kivalliq, although the trend of lower incident infections and diagnosed active TB disease cases remained with the rapid treatment scenario (Fig. [9a](#Fig9){ref-type="fig"}). With higher transmission occurring outside of the household (15% of respiratory contacts sufficient to transmit TB occurring in the community), expected TB incidence in the base case ranged from 44 to 562 over the 10-year period. Rapid treatment was projected to decrease TB incidence, and to a lesser extent, diagnoses of active TB disease (Fig. [9b](#Fig9){ref-type="fig"}). Expanded population screening showed a trend toward lower TB incidence and diagnoses, but there was a fair amount of variability in these findings.Fig. 9Impact of different assumptions around fraction of community transmission on model-projected TB incidence and diagnoses. (**a**) 1% and (**b**) 15% of respiratory contacts sufficient to transmit TB were assumed to occur within the community. The midpoint of boxes represents the median percent change in the outcome of interest, relative to the base case, with the upper and lower bounds representing the 25^th^ and 75^th^ percentiles of percent change, respectively and the bars indicating 1.5 times the interquartile range. Results are based on cumulative outcomes over a 10-year time horizon. Intervention details are provided in Table [2](#Tab2){ref-type="table"}

Given the slow progression of TB and the possible subsequent delay in observing impact of interventions on changes in disease dynamics, we repeated our analyses using a 25-year time horizon (Fig. [10](#Fig10){ref-type="fig"}). Rapid initiation of treatment for active TB cases remained the most attractive intervention option when considering the 25-year time horizon for all scenarios (1%, 5%, and 15% community transmission). With a longer time horizon, population screening, school screening programs, and increased housing were projected to have an overall minimal effect on reducing TB burden in the population. Under the assumption of a greater number of transmission events occurring among community contacts (15%) (Fig. [10](#Fig10){ref-type="fig"}), the rapid contact tracing intervention began to appear more attractive as an intervention, with all simulation runs resulting in a reduction in both incident and diagnosed active TB.Fig. 10Projected impact of different interventions on TB incidence and diagnoses over a 25-year period. Results are shown for 1% (top), 5% (middle), and 15% (bottom) of respiratory contacts occurring within the community. The midpoint of boxes represents the median percent change in the outcome of interest, relative to the base case, with the upper and lower bounds representing the 25^th^ and 75^th^ percentiles of percent change, respectively and the bars indicating 1.5 times the interquartile range. Intervention details are provided in Table [2](#Tab2){ref-type="table"}

Discussion {#Sec15}
==========

We have developed an agent-based model of TB transmission in the Kivalliq Region of Nunavut. Using this model, we evaluated the potential for different intervention strategies to control the spread of TB in this region. Although our results were sensitive to assumptions around the relative contribution of community transmission to TB spread, we generally found that reducing the time between onset of active disease and initiation of treatment was an effective means of reducing disease burden. In the short-term, expanding general population screening was also projected to reduce the burden of TB. Other potential interventions were expected to be of limited effectiveness.

Population screening and treatment of LTBI prevents the potential progression to active disease, with the downstream consequence of preventing ongoing TB transmission. Screening may also detect active TB cases \[[@CR5]\]. Given that most infected individuals will not progress to active TB disease \[[@CR24]\], many individuals need to be screened and treated to prevent a case of active disease \[[@CR25]\] and compliance with the lengthy treatment regimen can be a challenge \[[@CR24]\]. Despite these challenges, we found that population screening in Kivalliq was projected to reduce the burden of TB, although the effect was less pronounced when we considered a 25-year time horizon.

Implementing screening programs in school-aged children was not projected to impact TB burden. As pediatric cases are less likely to have highly transmissible TB \[[@CR26]\], it may be that finding and treating LTBI in this population is ineffective as a means of preventing disease transmission. Other targeted screening programs, focusing on population-groups considered to be at higher risk for TB infection or progression to active disease, or individuals who are at increased risk of transmitting TB to vulnerable individuals, might be expected to be of higher yield, but would require additional model complexity and data to evaluate.

We found that reducing the time to conduct contact tracing had minimal impact on disease dynamics. This finding is consistent with work by Tian et al. \[[@CR27]\], who used a system dynamic model describing TB in Saskatchewan to demonstrate that more rapid contract tracing did not significantly impact TB incidence. A previous modeling study \[[@CR11]\] found that follow-up of household contacts could reduce TB burden, but compared contact tracing to disease trends in the absence of any contact tracing, as opposed to investigating the role of reducing the time to perform contact tracing and initiate treatment as in the present study. Our findings suggest that the current time frame for contact tracing is adequate for detecting exposed individuals of index cases prior to their development of active infection. It is important to note that this model assumes that contact tracing is only applied to household members of active cases. It is possible that a model that included a more complex tracking of community contacts would observe a different impact of reducing contact tracing time, although, as mentioned above, the results of another mathematical modeling study suggest that expanded breadth of contact tracing has diminishing returns \[[@CR27]\].

Household overcrowding is a recognized issue in northern communities \[[@CR8]\]. Given the importance of household transmission for TB spread, we hypothesized that reducing the average number of individuals living in a household through the addition of households in communities would reduce TB transmission. However, we did not observe a significant impact on TB incidence when we implemented this intervention, although we did observe a trend toward lower TB incidence in our moderate community transmission scenario. It is possible that by allowing individuals to move between households (via the creation of new households), the effective number of contacts of an infectious individual actually increases. For instance, an active case might share a household with four others; if that person is then relocated to a new household with four other individuals, he has the opportunity to infect eight individuals over the course of his infection. Since contact tracing is only applied to an active case's household members at the time of diagnosis, we may be underestimating the potential for increased housing to impact TB spread. It is also possible that the impact of housing on reducing overcrowding (and downstream, transmission events) takes a longer time to manifest than that considered in this analysis. Finally, it may be that the actual number of new housing units required to significantly impact overcrowding is greater than that considered in this scenario. It should be noted that adding housing reduces average household size (and therefore the number of contacts) only. We did not model the possibility that new housing units with improved ventilation might reduce the probability of transmission per contact.

We assumed that household contacts of active cases were at greater risk of TB infection than community and casual contacts. As the degree to which community transmission contributes to TB transmission in Kivalliq is unknown, we conducted scenario analyses for differing amounts of transmission occurring in the community. The overall projected TB burden scaled with the assumed amount of community transmission, with lower levels of TB transmission expected to occur when transmission primarily occurs within the household. Based on past experience, it appears that the higher community transmission scenarios are more likely to reflect population mixing in Kivalliq. Given the importance of assumptions around the contribution of community transmission to TB dynamics, the use of molecular epidemiological techniques to better define transmission networks \[[@CR28]--[@CR30]\] might facilitate the selection of optimal disease control strategies. For example, the identification of large single-strain clusters that include both household contacts and community members would argue in favour of more community transmission, whereas the identification of sporadic strain types in the community, and with clusters restricted to household groups, would suggest less community-based transmission.

The failure to observe robust effects for any of the interventions in the low community transmission scenario may reflect the small absolute number of TB cases projected to occur. The median number of diagnosed cases was 20 (in the base case and in the absence of additional interventions), making it challenging to detect small or moderate differences in health outcomes upon introduction of additional interventions.

As with any model-based analysis, ours has limitations. This model includes a large number of parameters relating to the natural history of TB and treatment, many of which are subject to uncertainty \[[@CR31]\], and also includes many simplifying assumptions. Wherever possible, we have used parameters specific for Kivalliq, Nunavut, or Canada. We have assumed that the proportion of respiratory contacts sufficient to transmit TB in the community (outside of household contacts) ranged from 1 to 15%. Improved data on contact patterns between individuals would better inform our model parameterization: in particular, diary data recording specific contact patterns \[[@CR32]\], or a detailed contact-tracing registry. Although we were able to generate model realizations that fit the available surveillance data well, the variability in the possible trajectory of TB burden over the subsequent 10 years highlights the degree of uncertainty in our model projections. We made comparisons within model realizations to account for the differences in model projections and focused on relative differences to account for this uncertainty in model projections. We have also addressed this issue in supplementary analyses presented in the Additional file [1](#MOESM1){ref-type="media"}.

Conclusions {#Sec16}
===========

To summarize, we have developed an agent-based model describing TB transmission in a small northern population. We have identified possible areas of TB control where increased efforts are expected to have an impact, as well as areas where focusing efforts are not expected to have as great of a payoff, in terms of reduced TB burden in the community. This model provides a platform that can be refined as we gather additional surveillance and programmatic data and can be modified to represent different communities in Canada's north. In addition to providing qualitative estimates of the relative impact of different interventions and combinations of interventions, it can be used as a tool to identify knowledge gaps \[[@CR31]\].

Additional file {#Sec17}
===============

Additional file 1:Model technical appendix. (DOCX 497 kb)
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